Abstract
The presence of specific binding sites for phorbol esters was studied in a transformed but non-tumorigenic human urothelial cell line HCV-29 by assay of specific binding of3H-phorbol-12,13-dibutyrate (3H-PDBu) to intact living cells.3H-PDBu bound specifically to HCV-29 cells in a saturable and competitive manner. Scatchard plot analysis of specific binding yielded a curved plot consistent with two binding sites with Kd of 11 nM and 102 nM, respectively. At saturation the corresponding PDBu binding capacities (Bmax) were 8.8 pmol/106 cells (5.2×106 molecules bound per cell) and 2.8 pmol/106 cells (1.7×106 molecules bound per cell).3H-PDBu binding was displaced by biologically active phorbol ester tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and mezerein,but not by tumor promoters such as L-tryptophan, anthranilic acid and sodium saccharin. In cells desensitized by pretreatment with 1 μg/ml (2μM) TPA or PDBu for 24 h the level of binding was reduced to 28% of the level in non-exposed cells. The ability of desensitized cells to bind3H-PDBu was gradually restored within 5–6 days. At the same time the cells became sensitive to the morphological alteration induced by PDBu. This suggests that desensitization of HCV-29 cells is due to a decreased receptor-ligand binding capacity probably associated with down regulation of the phorbol ester receptors.
Similar content being viewed by others
References
Verma, A. K., Bryan, G. T., and Reznikoff, C. A., Carcinogenesis6 (1985) 427.
Verma, A. K., Erturk, E., and Bryan, G. T., Cancer Res.43 (1983) 5964.
Skouv, J., Christensen, B., Skibshøj, I., and Autrup, H., Carcinogenesis7 (1986) 331.
Skouv, J., Christensen, B., and Autrup, H., J. cell. Biochem.34 (1987) 71.
Autrup, H., Grafstrøm, R. C., Christensen, B., and Kieler, J., Carcinogenesis2 (1981) 763.
Nebelin, E., Autrup, H., Christensen, B., and Blomkvist, G., in: N-Nitroso-compounds: Occurrence and Biological Effects, p. 473. Eds H. Bartsch, I. K. ONeill, M. Castegnaro and H. Okado. IARC Scientific Publications No. 41, Lyon 1982.
Wang, C. Y., Christensen, B., Zukowski, K., Morton, K. C., and Lee, M.-S., J. natl Cancer Inst.72 (1984) 847.
Bem, W. T., Christensen, B., and Kieler, J., J. natl Cancer Inst.78 (1987) 197.
Skouv, J., Christensen, B., and Autrup, H., J. cell. Biochem.34 (1987) 71.
Christensen, B., Kieler, J., Vilien, M., Don, P., Wang, C. Y., and Wolf, H., Anticancer Res.4 (1984) 319.
Greenebam, E., Nicolaides, M., Eisinger, M., Vogel, R. H., and Weinstein, I. B., J. natl Cancer Inst.70 (1983) 435.
Philips, M., and Jaken, S., J. biol. Chem.258 (1983) 2875.
Collins, M. K. L., and Rozengurt, E., Eur. J. Cell Physiol.112 (1982) 42.
Gescher, A., and Reed, D. J., Cancer Res.45 (1985) 4315.
Jaken, S., Tashjian, A. H., and Blumberg, P. M., Cancer Res.41 (1981) 4956.
Jaken, S., Feldman, H., Blumberg, P. M. and Tashjian, A. H., Cancer Res.43 (1983) 5795.
Solanki, V., and Slaga, T. J., Proc. natl Acad. Sci. USA78 (1981) 2549.
Chida, K., and Kuroki, T., Cancer Res.43 (1983) 3638.
Yamasaki, H., Drevon, C., and Martel, N., Carcinogenesis3 (1982) 905.
Solanki, V., Slaga, T. J., Callahan, M., and Huberman, E., Proc. natl Acad. Sci. USA78 (1981) 1722.
Ottesen, S. S., Kieler, J., and Christensen, B., Eur. J. clin. Oncol.23 (1987) 991.
Skouv, J., Ottesen, S. S., Mark, G., and Autrup, H., Molec. Carcinogen.2 (1989) 59.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Christensen, B., Skouv, J., Kieler, J. et al. Two phorbol ester receptor affinities in partially transformed human urothelial cells and decrease of receptor binding in desensitized cells. Experientia 49, 80–83 (1993). https://doi.org/10.1007/BF01928796
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01928796